The global frontotemporal dementia therapeutics market is witnessing significant growth. This trend can be linked to a rising prevalence of frontotemporal dementia, coupled with progresses in research and creation of novel medications. The market is driven by a blend of factors, including an elderly population, rising healthcare expenditure, and st